Neurofibromatosis: Novel and Recurrent Mutations in Turkish Patients

Pediatric Neurology

Volumn 37, Issue 6, 2007, Pages 421-425

  Terzi, Yunus Kasim ^a   Oguzkan, Sibel ^b   Anlar, Banu ^a   Aysun, Sabiha ^a   Ayter, Sukriye ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CHILD; CHROMOSOME 17Q; EXON; FEMALE; GENE DELETION; GENE IDENTIFICATION; GENE LOCATION; GENE MUTATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROFIBROMATOSIS; NUCLEOTIDE SEQUENCE; PENETRANCE; PHENOTYPE; PRIORITY JOURNAL; RECURRENT DISEASE; RNA TRANSCRIPTION; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; EXONS; FAMILY HEALTH; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; MUTATION; NEUROFIBROMATOSIS 1; NEUROFIBROMIN 1; TURKEY;

EID: 36049021772     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2007.07.005     Document Type: Article

References (26)

1. Friedman J.M. Epidemiology of neurofibromatosis type 1. Am J Med Genet 89 (1999) 1-6
2. North K. Neurofibromatosis type 1. Am J Med Genet 97 (2000) 119-127
3. Friedman J.M., and Birch P.H. Type 1 neurofibromatosis: A descriptive analysis of the disorder in 1,728 patients. Am J Med Genet 70 (1997) 138-143
4. Gutmann D.H., Aylsworth A., Carey J.C., et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278 (1997) 51-57
5. Shen M.H., Harper P.S., and Upadhyaya M. Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet 33 (1996) 2-17
6. Zwarthoff E.C. Neurofibromatosis and associated tumour suppressor genes. Pathol Res Pract 192 (1996) 647-657
7. Xu G.F., Lin B., Tanaka K., Dunn D., et al. The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell 63 (1990) 835-841
8. Xu G.F., O'Connell P., Viskochil D., et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62 (1990) 599-608
9. Upadhyaya M., Osborn M.J., Maynard J., Kim M.R., Tamanoi F., and Cooper D.N. Mutational and functional analyses of the neurofibromatosis type 1 (NF1) gene. Hum Genet 99 (1997) 88-92
10. Kim M.R., and Tamanoi F. Neurofibromatosis type 1: From genotype to phenotype. In: Upadhyaya M., and Cooper D.N. (Eds). Neurofibromatosis 1 GTPase activating protein-related domain and its functional significance (1998), Bios Scientific, Oxford 89-112
11. Carmen Valero M., Pascual-Castroviejo I., Velasco E., Moreno F., and Hernandez-Chico C. Identification of de novo deletions at the NF1 gene: No preferential paternal origin and phenotypic analyses of patients. Hum Genet 99 (1997) 720-726
12. Upadhyaya M., Majounie E., Thompson P., et al. Three different pathological lesions in the NF1 gene originating de novo in a family with neurofibromatosis type 1. Hum Genet 112 (2003) 12-17
13. Tonsgard J.H., Yelavarthi K.K., Cushner S., Short M.P., and Lindgren V. Do NF1 gene deletions result in a characteristic phenotype?. Am J Med Genet 73 (1997) 80-86
14. Skuse G.R., and Cappione A.J. RNA processing and clinical variability in neurofibromatosis type I (NF1). Hum Mol Genet 6 (1997) 1707-1712
15. Fahsold R., Hoffmeyer S., Mischung C., et al. Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. Am J Hum Genet 67 (2000) 790-818
16. Upadhyaya M., Osborn M., Maynard J., and Harper P. Characterization of six mutations in exon 37 of neurofibromatosis type 1 gene. Am J Med Genet 67 (1996) 421-423
17. Bahuau M., Houdayer C., Assouline B., et al. Novel recurrent nonsense mutation causing neurofibromatosis type 1 (NF1) in a family segregating both NF1 and Noonan syndrome. Am J Med Genet 75 (1998) 265-272
18. Girodon-Boulandet E., Pantel J., Cazeneuve C., et al. NF1 gene analyses focused on CpG-rich exons in a cohort of 93 patients with neurofibromatosis type 1. Hum Mutat 16 (2000) 274-275
19. Messiaen L.M., Callens T., Mortier G., et al. Exhaustive mutation analyses of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat 15 (2000) 541-555
20. Toliat M.R., Erdogan F., Gewies A., et al. Analyses of the NF1 gene by temperature gradient gel electrophoresis reveals a high incidence of mutations in exon 4b. Electrophoresis 21 (2000) 541-544
21. Gutmann D. The neurofibromatoses: When less is more. Hum Mol Genet 10 (2001) 747-755
22. National Institutes of Health. Consensus Development Conference statement: Neurofibromatosis. Arch Neurol 45 (1988) 575-578
23. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1998) 1215
24. Hayashi K. PCR-SSCP: A method for detection of mutations. Genet Anal Tech Appl 9 (1989) 73-79
25. Han S., Cooper D.N., and Upadhyaya M. Evaluation of denaturing high performance liquid chromatography (DHPLC) for the mutational analysis of the neurofibromatosis type 1 (NF1) gene. Hum Genet 109 (2001) 487-497
26. Ars E., Kruyer H., Morell M., et al. Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients. J Med Genet 40 (2003) 82-90